Key result
Pravastatin reduced myocardial infarct size compared to control and increased eNOS expression in a rat model of ischemia/reperfusion.
Why the study?
Does pravastatin or fluvastatin reduce myocardial infarct size and increase eNOS expression in a rat model of coronary artery ischemia/reperfusion?
Does pravastatin or fluvastatin reduce myocardial infarct size and increase eNOS expression in a rat model of coronary artery ischemia/reperfusion?
Pravastatin and fluvastatin reduce myocardial infarct size and increase eNOS expression in a rat model of ischemia/reperfusion, suggesting cardioprotective pleiotropic effects beyond cholesterol lowering.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for statin pleiotropy in rat ischemia/reperfusion; leaves open clinical translation.
Our previous study showed that pravastatin prevents ischemia and reperfusion-induced lethal ventricular fibrillation in rats. This study explored whether pravastatin decreases myocardial infarct size and this effect is associated with endothelial nitric oxide synthase (eNOS) expression in myocardium. Rats were treated with ischemia (30 minutes) and reperfusion (60 minutes) after chronic oral administration of pravastatin, fluvastatin, or vehicle once daily for 22 days. Electrocardiograms and blood pressure were continuously recorded, myocardial infarct size was measured by TTC-staining, and eNOS expression was measured by western blot. The results showed that pravastatin and fluvastatin significantly reduced myocardial infarct size. No statistical differences were found in the areas at risk among all groups. However, a significant reduction in infarct size was observed in three pravastatin groups and one fluvastatin group compared to control. Both pravastatin and fluvastatin significantly increased eNOS protein expression in ischemic and non-ischemic tissues compared to control. Our results suggest that pravastatin decreases cardiovascular mortality beyond its cholesterol-lowering effect. Pravastatin is more potent than fluvastatin in reducing infarct size. These effects may be associated with elevation of eNOS expression.
No takes yet. Share an insight, caveat, or question.
He et al. (2018) studied Coronary artery ischemia/reperfusion injury (n=100). Pravastatin and Fluvastatin vs. Vehicle (distilled water) was evaluated on Infarct area (percentage of total left ventricular area) (p=<0.01). Pravastatin reduced myocardial infarct size compared to control and increased eNOS expression in a rat model of ischemia/reperfusion.
Synapse has enriched 10 related papers. Consider them for comparative context: